| EMA number | EMEA/H/C/001135 |
| ATC code | B01AC06 |
| Authorisation | 23 September 2009 |
| Withdrawn | 1 September 2014 |
| Revision | 4 |
Clopidogrel is indicated in adults for the prevention of atherothrombotic events in: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. For further information please refer to section 5.1.